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46 Abstract
47
48 A consensus workshop on low calorie sweeteners (LCS) was held in November 2018 where 
49 seventeen experts (the panel) discussed three themes identified as key to the science and 
50 policy of LCS: (1) weight management and glucose control; (2) consumption, safety and 
51 perception; (3) nutrition policy.  The aims were to identify the reliable facts on LCS, suggest 
52 research gaps and propose future actions. The panel agreed that the safety of LCS is 
53 demonstrated by a substantial body of evidence reviewed by regulatory experts and current 
54 levels of consumption, even for high users, are within agreed safety margins.. However, 
55 better risk communication is needed. More emphasis is required on the role of LCS in 
56 helping people reduce their sugar and energy intake, which is a public health priority. Based 
57 on reviews of clinical evidence to date, the panel concluded that LCS can be beneficial for 
58 weight management when they are used to replace sugar in products consumed in the diet 
59 (without calorie substitution). The available evidence suggests no grounds for concerns 
60 about adverse effects of LCS on sweet preference, appetite or glucose control ; indeed, LCS 
61 may improve diabetic control and dietary compliance. Regarding effects on the human gut 
62 microbiota, data are limited and do not provide adequate evidence that LCS affects gut 
63 health at doses relevant to human use.   The panel identified research priorities, including 
64 collation of the totality of evidence on LCS and body weight control, monitoring and 
65 modelling of LCS intakes, impacts on sugar reduction and diet quality and developing 
66 effective communication strategies to foster informed choice. There is also a need to 
67 reconcile policy discrepancies between organisations and reduce regulatory hurdles that 
68 impede low energy product development and reformulation.   
69
70 Introduction and aim of the Consensus Report
71
72 A number of reviews, some narrative and some systematic, have discussed the evidence for 
73 the safety of LCS and their effects on appetite, food intake, body weight, glucose control and 
74 other health outcomes (1) (2) (3; 4; 5; 6) (7) (8). Evidence has also been evaluated by authorities 
75 such as the European Food Safety Authority (EFSA), the (US) Dietary Guidelines Advisory 
76 Committee (DGAC), the French Agency for Food, Environmental and Occupational Health & 
77 Safety (ANSES) and Public Health England (PHE), who have issued statements or opinions 
78 on the use of low calorie sweeteners (9) (10; 11; 12; 13). Other groups of scientific experts 
79 have generated consensus statements, position papers, or other statements on LCS. These 
80 include the British Dietetic Association, Diabetes UK, the American Heart Association and 
81 American Diabetes Association (AHA/ADA) (14) (15) (16) (17) (18; 19) (20).
82
83 This paper describes the results of a workshop in which seventeen experts convened to 
84 discuss and debate the science and policy relating to the use of LCS. The aims were to 
85 establish via consensus-forming techniques, clear and simple statements on LCS that all the 
86 panel agreed (facts), to highlight the areas where more research is required (gaps) and to 
87 propose how progress might be achieved (actions).  It is hoped that the provision of these 
88 statements on safety and potential benefits of LCS will assist health practitioners and policy 
89 makers to promote consistent messages and develop strategies based on sound science.  
90 Identification of the gaps and actions will help promote better study designs, suggest 
91 priorities for research funding and thereby encourage more coherent public health policy.
92 Background to LCS and their regulatory approval process
93
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94 All LCS have undergone an extensive safety evaluation process by international and 
95 national regulatory food safety bodies both before and after their approval for use in the 
96 market.  The Food and Agriculture Organization (FAO)/World Health Organization (WHO) 
97 Joint Expert Committee on Food Additives (JECFA) (21), the US Food and Drug 
98 Administration (FDA) (22), and EFSA (9), have confirmed the safety of all approved LCS as 
99 food additives. Hence there is an extensive body of evidence from both animal models and 
100 human studies that support the safety of LCS. Each compound is considered individually as 
101 their characteristics, metabolism and metabolic fates are different (23). Furthermore, there is 
102 an ongoing review process to ensure that any new information on safety is evaluated, for 
103 example recent scientific opinions by EFSA on aspartame and sucralose (24) (25).
104
105 As part of the LCS safety evaluations, the regulatory authorities establish the Acceptable 
106 Daily Intakes (ADI) for each sweetener (26). The ADI is defined as an estimate of the amount 
107 of a food additive, expressed per kg bodyweight, that can be ingested daily by individuals 
108 over a lifetime without appreciable risk to health. ‘Without appreciable risk’ means, based on 
109 the current knowledge, “certainty that no harm will result, even after a lifetime of exposure to 
110 the additive” (27). The current ADIs for LCS were established using the ‘No Observed 
111 Adverse Effect Level’ (NOAEL).  This is the highest dietary level of an additive at which no 
112 adverse effects were observed in animal studies. The ADI is typically set at 1/100th of the 
113 NOAEL (10-fold reduction for inter-species variation and 10-fold reduction for intra-species 
114 variation) to give a large margin of safety for even the most sensitive consumer. The ADI 
115 refers to a lifelong exposure situation, not a single occasion, and thus infrequent 
116 consumption of levels higher than the ADI are not a health concern. Because of the large 
117 safety margin used in setting the ADI, it is likely that an ADI for a given additive would have 
118 to be exceeded by some considerable amount for an extended period of time for there to be 
119 any risk of harm to human health.  However, if an intake estimate indicates that the ADI may 
120 be regularly exceeded by certain sectors of the population, the regulatory authority may 
121 advise a reduction of levels in foods, or to reduce the range of foods in which the additive is 
122 permitted for use (27).  In some cases, the ADI may be “not specified” when the total 
123 potential intake from all possible sources does not represent a hazard to health, and hence 
124 no numerical ADI is needed. It should be noted that, in the future, the Benchmark Dose 
125 (BMD) will be the preferred approach for establishing a reference point (28).  However, 
126 discussion of the expert considerations and data requirements for calculation of a BMD is 
127 beyond the scope of this paper. 
128
129 In relation to efficacy, EFSA has a system for evaluating dossiers of evidence submitted for 
130 the substantiation of health claims (29).  In 2011, the EFSA Panel on Nutrition, Novel Foods 
131 and Food Allergens (NDA) concluded that there was sufficient scientific evidence to support 
132 the claims that intense sweeteners, like all sugar replacers, lead to a lower rise in blood 
133 sugar levels after meals if consumed instead of sugars, and maintain tooth mineralisation by 
134 decreasing tooth demineralisation; again if consumed instead of sugars. However at that 
135 time, EFSA’s experts found no clear cause and effect relationship to substantiate the claims 
136 that intense sweeteners when replacing sugars maintain normal blood sugar levels, or 
137 maintain/achieve a normal body weight (30).
138
139 There are currently various jurisdiction-specific restrictions on the use of LCS in foods and 
140 beverages. For example, under European legislation, sweeteners are only permitted if used 
141 to replace sugars for the production of energy-reduced food (i.e. with 30% less energy), non-
142 cariogenic food, or food with no added sugars (31). This limits the options available to 
143 manufacturers for more modest reformulation or stepwise reduction of sugar content in food 
144 and drink through the use of sweeteners.  
145  
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146 Methods 
147
148 The consensus workshop was designed to follow a conference held by the International 
149 Sweeteners Association (ISA) in London on 6th November 2018 entitled ‘The science behind 
150 low calorie sweeteners: where evidence meets policy’. The panel members were all 
151 speakers or chairs at that conference, chosen for their international expertise in LCS science 
152 and policy. The workshop was chaired and facilitated by two independent consultants in 
153 nutrition science, (MA and SG), who drafted the paper and coordinated responses from 
154 participants. The ISA provided funds for the venue and speakers’ expenses. They were 
155 observers at the workshop but had no control over the paper..  Disclosures of interest for all 
156 authors are given.
157 The workshop leaders (MA and SG) identified 3 key Themes or topic areas for discussion at 
158 the workshop: 
159
160 1) Role of low calorie sweeteners in weight management and glucose control 
161 2) Consumption and safety of low calorie sweeteners and consumer perception 
162 3) Role of low calorie sweeteners in relation to nutrition policy 
163
164 As the workshop was time-limited the choice of themes was based on the pertinence in 
165 terms of current debates on LCS, and the available expertise represented by the panel.         
166
167 Prior to the workshop, each panel member was asked to provide feedback on 3 questions 
168 with respect to their own area of expertise:
169  
170 a. Statements of fact: what do we know? 
171 b. Questions and type of evidence needed (gaps: what do we still need to know?)
172 c. How this might translate to further research work or policy (actions: what should we 
173 do?). 
174
175
176 Comments were minimally edited by MA and SG to produce the Working Document (WD) 
177 with provisional statements/questions/actions for each Theme. 
178
179 At the workshop all the participants discussed the WD in detail. A scoring system (1=strongly 
180 disagree to 10=strongly agree) was used to evaluate level of agreement on the ‘facts’. 
181 Statements that achieved a high level of agreement were discussed further. Participants 
182 refined the wording of each statement to reach consensus. Having established agreement 
183 on the facts, participants identified the major gaps or research questions.  Finally, 
184 participants identified the most important ‘actions’ suggested in the WD and these were then 
185 summarised. Participants agreed to the process for further review and publication, i.e. that 
186 the workshop leaders would circulate the draft consensus document for comments, integrate 
187 responses and write the discussion before presenting the final article to all participants for 
188 review and approval. Table 1 shows the Timeline of the project.
189
190 Results
191
192 The results are given below in the form of the consensus statements for the three Themes 
193 and the three questions relating to each Theme. The panel agreed the most pertinent 
194 references to cite for each consensus statement. 
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195 Theme 1: Role of low calorie sweeteners in weight management and 
196 glucose control: the scientific evidence
197
198 1a Facts - What we know
199
200 1. When substituted for sugars to reduce energy density of foods and drinks, LCS 
201 reduce net energy intake and assist weight management (3; 5) (12) (13).
202
203 2. Intervention studies have shown that beverages containing LCS have at least a 
204 similar effect on appetite and energy intake to water (5; 32).
205
206 3. The collective evidence supports the conclusion that LCS have no adverse effect on 
207 blood glucose and insulin regulation (HbA1c, fasting and post-prandial glucose and 
208 insulin levels) in people with, and without, diabetes (2; 33) (34)
209
210 4. The potential value of LCS in dietary management of diabetes derives from their role 
211 as substitutes for sugars, and hence carbohydrates. (19).
212
213 5. Confounding by adiposity, and reverse causality can explain the positive association 
214 between LCS and T2DM and other cardiometabolic diseases, reported in some 
215 observational studies. (35) (36) (37).
216
217 6. Regarding effects involving the human gut microbiota, data are limited and do not 
218 provide adequate evidence that LCS influence gut health at doses relevant to human 
219 use.(38)
220 1b Gaps:  What we don't know   
221
222 1. What are the long-term effects of LCS on glucose tolerance, gut function, 
223 cardiometabolic effects, gut microbiota and weight management?
224
225 2. How are these effects altered according to personal factors, such as age, sex, 
226 ethnicity, socio-economic status, health status, diet and lifestyle?
227
228
229 3. How do these effects differ according to dietary context (ad lib vs. weight-control diet) 
230 and form of LCS (in liquids or solids), and type or blend of LCS?
231
232 4. Does reducing exposure to sweetness have consequences for food choice and 
233 intake in the medium-to-long term? 
234
235
236 5. Can LCS help improve long term Type 2 diabetes (T2DM) management, when part of 
237 standard dietary and lifestyle approaches? 
238
239 1c Actions - What should be done?
240
241 1. There is a need for a portfolio of well-designed RCTs (with appropriate time frame of 
242 a year or more) with different comparators and different carriers of LCS (food and 
243 beverage matrices). The trials should be conducted by level of ‘free sugar’ intake in 
244 different populations; they should use multiple endpoints (diet quality, gut microbiota 
245 function and metabolomics, and wider health and quality of life measures). They 
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246 should be done in the context of weight-control diets, including for T2DM and also in 
247 non-restrictive diets.
248
249 2. There is a need for population cohort studies to model changes in weight/ 
250 cardiometabolic risk in the context of changes in LCS consumption, not baseline LCS 
251 values. The studies should include substitution analysis (e.g. LCS beverages for 
252 caloric beverages, water, etc.) and adjustment for adiposity. Their data should be 
253 made available for further analysis. 
254
255
256 3. There is a need for a collation of evidence to support future health claim submissions 
257 for LCS and body weight control, as data become available.
258
259 Theme 2 - Consumption and safety of low calorie sweeteners and consumer 
260 perception 
261 2a Facts - What we know
262
263 1. The safety of LCS is demonstrated by a substantial body of evidence as well as 
264 continued review by independent regulatory agencies/committees including 
265 JECFA/Codex, FDA and EFSA (21) (22) (9). These organisations have taken into 
266 account of the decades of both positive and negative human and animal studies to 
267 draw their conclusions.  Continual monitoring and modelling of LCS exposures is 
268 undertaken and this demonstrates that intakes of LCS, even among high 
269 consumers, are within ADIs (39; 40) (41).
270
271 2. Currently, the major sources of LCS in the Western diet are beverages and table top 
272 sweeteners (39; 40; 42). 
273
274 3. LCS can be used to reduce the sugar and energy content of beverages and some 
275 foods whilst maintaining a similar sensory profile. The potential for energy reduction 
276 is more limited in foods and depends on the options for reformulation and what 
277 replaces the bulk of sugar (43). LCS can be used synergistically in blends to achieve 
278 the desired sensory profile at lower levels of use.   
279
280 4. The collective evidence supports the conclusion that there is no relationship 
281 between adiposity and liking/ preference for sweet taste in either adults or 
282 children(44).
283
284 5. Consumer perceptions vary with regard to LCS, with some people having concerns 
285 about their potential health effects (14; 20).
286 2b Gaps – What we don't know
287
288 1. Which factors (including knowledge, attitudes and behaviours) influence consumer 
289 perception of risks and benefits of LCS consumption?  Are these the same for health 
290 professionals? 
291
292 2. There is a need for in-depth data relating to current patterns of LCS consumption at 
293 multiple levels, and across countries and regions, to strengthen the evidence base.  
294
295 3. There is a need for more reliable measures of LCS exposure, such as biomarkers. 
296 Further development of these and better linkage of food composition and dietary 
297 databases is needed to help monitor changing use and consumption of LCS. 
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298 2c Actions - What should be done?
299
300 1. There is a need to research and develop evidence-based strategies to communicate 
301 all of the above to consumers, health professionals and policy makers. The extensive 
302 body of scientific evidence that backs regulatory approval and the on-going safety 
303 assessment of LCS can then encourage better informed public health decisions. The 
304 media or other organisations could be provided, for example, with simple 
305 explanations of the ADI. 
306
307 2. There is a need to develop communications to foster more informed public attitudes 
308 towards LCS, for example by emphasizing the potential health gains associated with 
309 sugar (and energy) intake reduction and the role of LCS in achieving this. It is 
310 important to explain that the overall impact of LCS will depend on the amount of 
311 sugars replaced in the diet and the overall reduction in calorie (energy) intake that 
312 ensues. Use of LCS alone cannot be expected to act as a ‘silver bullet’ for weight 
313 loss.
314
315
316 3. Research into biomarkers for individual LCS is needed to complement the exposure 
317 assessment based on consumption records. There is a need to improve linkage of 
318 databases and to model intakes in future scenarios.   
319
320 Theme 3 - Role of low calorie sweeteners in relation to nutrition policy 
321
322 3a Facts - What we know
323
324 1. Reduction in the intake of ‘free sugars’ and ‘added sugars’ is being recommended 
325 around the world to reduce the risk and prevalence of obesity, which is a major public 
326 health concern (10) (45) (46). LCS is one of the strategies to consider.
327
328 2. LCS can be useful in dietary approaches to both prevent and manage diabetes and 
329 obesity. Benefit will depend on how foods and beverages containing LCS are 
330 substituted, as well as on the overall quality of the diet and the overall energy 
331 provision (16).
332
333 3. Despite repeated and consistent reassurances from food safety authorities, there is 
334 still some distrust of LCS among health professionals and policy makers. (47)
335
336 4. Some policies acknowledge LCS consumption as a useful strategy to reduce sugars 
337 intake (12).  However, there are discrepancies with other national and international 
338 policies (10; 11) and regarding use in children. 
339 3b Gaps - What we don't know
340
341 1. Can LCS help individuals meet the population level dietary recommendations for 
342 reduction of sugars intake  (e.g. to 5% (average) (48) or 10% (for individuals) (10; 45)?  
343 If so, how can this be achieved? 
344
345 2. How does a dietary approach that includes LCS-sweetened foods and drinks affect 
346 dietary quality compared to low-sugar diets?
347
348
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349 3. What are the best strategies to communicate LCS safety and efficacy to interested 
350 parties such as health professionals and the general public?
351  
352 3c Actions - What should be done?
353
354 1. There is a need to model the potential for LCS to reduce sugar content and sugar 
355 intakes whilst ensuring that other dietary recommendations can also be met in the 
356 overall diet. 
357
358 2. Trends in dietary intake of LCS need to be monitored, linked with food and beverage 
359 reformulation and ultimately with health outcomes.  
360
361 3.  Policies relating to LCS from different countries should be reviewed to compare their 
362 remit, priorities, evidence base and interpretation.
363
364 4. To help reconcile policy discrepancies, policy makers, scientists and regulatory 
365 affairs experts should agree on their understanding of the role of LCS in the diet.
366
367 5. In the context of sugar reduction and obesity, it would be helpful to review the 
368 regulatory and public health policy hurdles that prevent wider use of LCS in food 
369 products for those sweeteners where dietary intake is very low compared to the ADI.
370
371 DISCUSSION
372 Strengths and limitations of approach
373
374 The methodology followed a planned and transparent process. All 17 experts were 
375 requested ahead of the workshop to generate a summary of their topic in the form of 
376 answers to the three questions. These were then collated under three Themes by the 
377 workshop leaders and combined for the working document, which was circulated prior to the 
378 workshop. At the start of the group discussion, scoring was used as a consensus-forming 
379 technique to allow participants to indicate the strength of their agreement with each 
380 statement. Alternative forms of wording suggested by participants were considered in order 
381 to improve clarity of each statement. The resulting statements were circulated after the 
382 workshop, with supporting references, to allow for further reflection and improvement. A 
383 strength of the process was the expertise represented on the panel in many aspects of LCS 
384 (including toxicology, regulation, food science, medicine, microbiology, psychology, 
385 epidemiology, public health nutrition and dietetics).  Finally, holding the workshop 
386 immediately after a scientific conference on the topic ensured that all experts were fully 
387 prepared and engaged to discuss the issues and formulate consensus. 
388
389 The workshop was wide in scope but was not intended to be exhaustive; the themes were 
390 selected as being pertinent to current debate on LCS and within scope of the expertise of the 
391 panel. Consensus was based on expert opinion and key references including systematic 
392 reviews; the group did not review all the primary literature on these themes. Other possible 
393 limitations of the methodology were that all our participants were scientists or public health 
394 experts, unlike the broader stakeholder panel used by Bright et al. (49).  The workshop was 
395 instigated and funded by ISA; however, ISA had no control over the choice of Themes, and 
396 no role in the discussion or this paper. Participants all acted completely independently to 
397 express their views in open debate and to contribute to the resulting paper. 
398
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399 Comparison with other consensus papers relating to LCS 
400 Goals and methodology
401 To our knowledge, there have been three previous papers published in English that contain 
402 consensus statements about LCS (14) (15) (49). In addition, there have been a number of 
403 position papers and evidence reviews whose methodology and scope differ from that of the 
404 present report and these are discussed later. 
405 The goal of the consensus report by Gibson et al. (14) was to summarise the role and 
406 potential benefits of LCS on appetite, energy intake, body weight, diabetes and dental health 
407 to give clarity to health professionals and educators on use of LCS. The goal of the Ibero–
408 American Consensus on LCS (15) was “to develop a consensus on the use of low- and no-
409 calorie sweeteners as substitutes for sugars and other caloric sweeteners in line with current 
410 international public health recommendations, in the context of the prevention and treatment 
411 of obesity and related diseases in Latin American countries”. The report (15) also provides a 
412 comprehensive overview of the position of international and national regulatory bodies on 
413 LCS safety and efficacy studies on individual LCS. Both these consensus reports (14) 15) 
414 were compiled by panels limited to international scientists and public health experts.  
415 The report by Bright et al. (49), focused on future research needs, and involved a wider 
416 stakeholder panel who participated in interactive webinars, surveys and interviews with the 
417 research team and generated a list of 18 questions across 5 broad research areas, ranking 
418 them in order of priority. The stakeholder panel was recruited according to the “7 P’s” of 
419 stakeholder engagement  i.e. patients, providers, researchers, policymakers, product 
420 makers, payers, and purchasers (50). It therefore included policymakers, lay audience 
421 members, health providers, a research funder, individuals with food industry experience, and 
422 researchers of several different specialties. 
423 Content and conclusions
424 The consensus statements agreed by our expert panel were produced independently but 
425 have been compared with previous consensus statements in Table 2. Further details can be 
426 found in supplementary Tables S1 and S2. Some topics were not covered in other reports: 
427 for example, the statements in this paper have included association between sweetness 
428 preference and obesity, effects of LCS on gut bacteria and sources of LCS, which were not 
429 covered by Gibson et al. (14)or Serra-Majem et al. (15); conversely, this panel did not 
430 consider the effects of LCS on dental health. 
431 Table 2 shows there was broad agreement between the sentiments expressed in our 
432 statements and these two reports.
433
434 The gaps identified by our panel have been compared with the research priorities from Bright 
435 et al. (49) (Table S3).  Most of the important future research questions identified by their 
436 stakeholder panel were also selected by our panel as areas in need of study. In the case of 
437 effects of LCS beverages on appetite and energy intake (Bright et al. (49) Q2), our panel 
438 considered the evidence to be sufficiently strong for ‘no effect or at least similar effect’ 
439 compared to water to be classed as fact, and for a reduction in energy intake compared to 
440 sugar also to be classed as fact.  Research gaps identified by our panel and not identified by 
441 Bright et al. (49) included research on biomarkers of LCS consumption to aid intake 
442 assessments, research on communication with consumers and other stakeholders about 
443 LCS and more research on issues related to policy. Conversely Bright’s (49) questions on the 
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444 sensing of LCS by the brain and the impact of LCS on the fetus, did not feature directly in 
445 our workshop discussion.
446 Comparison with other reviews and position statements  
447  
448  In 2011 EFSA was of the opinion that a cause and effect relationship had not been 
449 established between the use of intense sweeteners and maintenance of normal body weight 
450 or blood glucose, but several high quality studies and reviews have since been published 
451 (51) (52) (53; 54) and others are currently underway: the SWITCH project (55) and the SWEET 
452 project;(available at  https://sweetproject.eu) .  A number of reviews and position statements 
453 have addressed the evidence for and against health benefits of LCS. Our panel observed 
454 that differences between the positions and policies of different organisations with regard to 
455 LCS are a cause of confusion. Reasons for discrepancies may include different remits and 
456 approaches. The goal of systematic review and meta-analysis is frequently hampered by 
457 differing study designs that make comparison difficult and meta-analysis unreliable; hence 
458 the need for cautious wording, which may be interpreted as a negative statement.. It is 
459 important to clearly establish that LCS are food additives and, as such cannot provide health 
460 benefits, except in relation to the reduction of sugar within an adequate diet and lifestyle. Our 
461 panel concluded that, when used to replace dietary sugar, the use of LCS facilitates 
462 reduction in energy intake and weight loss. This was based on evidence from RCTs of 6m to 
463 2 years in length and recent systematic reviews that pay careful attention to appropriate 
464 comparators. The panel also stated the need for studies of longer-term effects. By contrast, 
465 a recent wide-ranging review on health effects of non-sugar sweeteners (which in practice 
466 were LCS as polyols were excluded.) concluded that “there were no significant or clinically 
467 important effects on most outcomes” (8). However due to very strict inclusion and exclusion 
468 criteria, their analyses omitted some notable studies on body weight  (51; 52),(53) (54) and 
469 combined studies with different comparato s, potentially diluting the effect size (56).  Another 
470 recent review (57) has been criticised on the same grounds (37). Toews et al. (8) also stated 
471 that “potential harms from the consumption of non-sugar sweeteners could not be excluded”, 
472 a statement which relates to lack of evidence, not evidence of harm. Our panel took a harm-
473 reduction approach, where LCS are a desirable substitute for sugar and one route to helping 
474 achieve sugar and energy reduction whilst still maintaining dietary diversity and pleasure.   
475
476 Other position statements, particularly those published before 2014, have offered cautious 
477 conclusions on potential benefits of LCS. For example, the 2012 joint scientific statement 
478 from the American Heart Association and the American Diabetes Association (AHA/ADA)  
479 concluded that “at present there are insufficient data to determine conclusively that non-
480 nutritive sweeteners (NNS) benefit appetite, energy intake or body weight” (20). However, the 
481 AHA/ADA document also stated that “when used judiciously, NNS could facilitate reductions 
482 in added sugars intake, thereby resulting in decreased total energy and weight loss/weight 
483 control and promoting beneficial effects on related metabolic parameters”. 
484
485 The latest AHA advisory statement (19) (which focussed on LCS beverages and 
486 cardiometabolic outcomes) concluded that the use of LCS beverages may be an effective 
487 strategy to help control energy intake and promote weight loss. Nonetheless due to the lack 
488 of long-term trials in children, the AHA thought it prudent to advise against prolonged 
489 consumption of LCS beverages by children, preferring water, other unsweetened beverages 
490 or milk as the primary drink. Policy statements from professional bodies of dietitians and 
491 nutritionists have generally been pragmatic, seeing LCS as a helpful tool in helping people 
492 reduce their sugar intake and manage their weight in the context of a healthy balanced diet 
493 that meets other dietary recommendations (16) (17; 18). 
494 Extension of our consensus statements to actions and policies 
495 The main strategy of our consensus workshop was to stimulate forward thinking as well as to 
496 restate principles. The consensus statements on actions put the focus firmly on what is 
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497 required to deliver. For example, the panel made recommendations for further long-term 
498 randomised controlled trials of LCS with different comparators and multiple endpoints, for 
499 prospective studies that control for adiposity and other confounders, and for better estimates 
500 of LCS exposure. Such recommendations may help research funding bodies select priorities. 
501 Clarity and consistency of policy would be improved by a comprehensive evaluation of all the 
502 evidence on effects of LCS.  Others have also called for larger and longer clinical trials with 
503 careful selection of comparators (7) (37) (44) (58). The review by Toews et al. (8) was also 
504 critical of the size, short duration, and methodological and reporting quality of studies. It also 
505 called for more data on benefits and risks of non-sugar sweeteners in doses and patterns 
506 more akin to real life consumption (8). Our expert panel considered the safety data to be 
507 robust but agreed that there is a continued need for ongoing exposure assessment to 
508 account for changing LCS use, and also consideration of any new evidence that might 
509 emerge. Novel recommendations made by the panel included better strategies and methods 
510 to improve communications about the safety and efficacy of LCS, modelling of the effect of 
511 LCS on sugar reduction and diet quality, relaxing regulation to increase the potential for 
512 reformulation using LCS, and review and reconciliation of policy differences on the use of 
513 LCS.  
514
515 Conclusion
516
517 The panel considered that the substantial body of evidence concerning LCS safety should 
518 be communicated in a consistent manner. More emphasis is required on the role of LCS in 
519 helping people reduce their sugar and energy intake, which is a public health priority. 
520
521 Research priorities should include 
522 a. a dossier of the totality of evidence on LCS and body weight control, 
523 b. studies to monitor and model LCS intakes and their impact on sugar reduction and 
524 diet quality,
525 c. effective communication strategies to inform consumers, non- governmental 
526 organisations (NGOs), health professionals, research funding bodies and the food 
527 and beverage industry 
528
529 Efforts should be made to understand and, where possible, reconcile policy discrepancies 
530 between organisations and reduce regulatory hurdles that impede product development and 
531 reformulation designed to reduce sugars and/or calories. 
532
533 It is hoped that these consensus statements and recommendations arising from the expert 
534 workshop will assist policy makers, and other stakeholders including NGOs, health 
535 professionals, research funding bodies and the food and beverage industry.
536
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744 Table 1: Timeline of the project
745
January 2018 Identification of ISA conference speakers and chairs 
April 2018 Workshop leaders (MA & SG) appointed
Conference speakers and chairs invited to workshop
May 2018 Three key workshop Themes identified by workshop 
leaders
May 2018 Workshop leaders agree questions for experts based on 
the 3 Themes for workshop
July 2018 Experts asked to provide provisional answers to questions
September 2018 Workshop leaders collate expert comments into working 
document
November 6th, 2018 ISA Conference
November 7th, 2018 Expert workshop
November 2018 Draft consensus statements agreed at workshop, 
circulated to experts
December 2018 Comments received from experts
December 2018- January 
2019
Draft paper written by workshop leaders
January 2019 Draft paper circulated to experts for approval
February 2019 Paper finalised and submitted to journal
July and August 2019 Revisions to paper agreed by panel
746
747
748
749
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750
751 Table 2: Comparison of our consensus statements on LCS with those of 
752 others.
753 (+ = broad correspondence with our Consensus statements; blank = not (or not 
754 fully) addressed) 
755
Theme 1:
Role of low calorie sweeteners in weight management and glucose 
control: the scientific evidence
Gibson 
et al 
(2014) 
(14)
Serra- 
Majem 
et al ( 
2018) 
(15)
1. When substituted for sugars to reduce energy density of foods 
and drinks, LCS can reduce net energy intake and assist weight 
management.
+ +
2. Intervention studies have shown that LCS beverages have at 
least a similar effect on appetite and energy intake to water +
3. The collective evidence supports the conclusion that LCS have no 
adverse effect on blood glucose and insulin regulation (HbA1c, 
fasting and post-prandial glucose and insulin levels) in people 
with, and without, diabetes 
+ +
4. The potential value of LCS in dietary management of diabetes 
derives from their role as substitutes for sugars. and hence 
carbohydrates. 
+ +
5. Confounding by adiposity, and reverse causality can explain the 
positive association between LCS and T2DM and other 
cardiometabolic diseases, reported in some observational 
studies. 
+
6. Regarding effects involving the human gut microbiota, current 
evidence is limited and does not provide adequate evidence that 
LCS influence gut health at doses relevant to human use. 
Theme 2:
Consumption and safety of low calorie sweeteners and 
consumer perception
1. The safety of LCS is demonstrated by a substantial body of 
evidence as well as continued review by independent regulatory 
agencies/committees including JECFA/Codex, FDA and EFSA 
These organisations have taken into account of the decades of 
both positive and negative human and animal studies to draw 
their conclusions.  Continual monitoring and modelling of LCS 
exposures is undertaken and this demonstrates that intakes of 
LCS, even among high consumers, are within ADIs
+
2. Currently, the major sources of LCS in the Western diet are 
beverages and table top sweeteners 
3. LCS can be used to reduce the sugar and energy content of 
beverages (and some foods) whilst maintaining a similar sensory 
profile. The potential for energy reduction is more limited in foods 
and depends on the options for reformulation and what replaces 
the bulk of sugar. LCS can be used synergistically in blends to 
achieve the desired sensory profile at lower levels of use
+ +
4. The collective evidence supports the conclusion that there is no 
Page 18 of 43
Cambridge University Press
Nutrition Research Reviews
For Peer Review
18
relationship between adiposity and liking/ preference for sweet 
taste in either adults or children
5. Consumer perceptions vary with regard to LCS, with some people 
having concerns about their potential health effects + +
Theme 3:
Role of low calorie sweeteners in relation to nutrition policy
1. Reduction in the intake of ‘free sugars’ and ‘added sugars’ is 
being recommended around the world to reduce the risk of 
obesity, which is a major public health concern. LCS should be 
one of the strategies to consider.
+ +
2. LCS can be useful in dietary approaches to both prevent and 
manage diabetes and obesity. Benefit will depend on how foods 
and beverages containing LCS are substituted, as well as on the 
overall quality of the diet and the overall energy provision.
+ + 
3. Despite repeated and consistent reassurances from food safety 
authorities, there is still some distrust of LCS among health 
professionals and policy makers 
+ +
4. Some polices acknowledge LCS consumption as a useful 
strategy to reduce sugars intake However, there are 
discrepancies with other national and international policies and 
regarding use in children. 
+ 
756
757
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759 Supplementary information 
760
761 Comparison of Consensus statements from others with the Consensus 
762 statements in this paper
763
764 Table S1: Conclusions from Gibson et al. (2014)
765
Relevant to our 
consensus 
statement
Blank = not 
addressed
(1) LCS do not increase appetite and have no discernible effect on 
satiety
1a2
(2).LCS help to reduce energy when used in place of higher energy 
ingredients
1a1
(3).LCS can enhance weight loss under real-life conditions when used as 
part of a behavioural weight loss programme
1a1
(4).LCS may have a beneficial effect on post-prandial glucose and insulin 
in healthy individuals and in people with diabetes
1a3
1a4
(5).LCS have dental benefits when used in food, beverages, toothpaste 
and medications, provided other constituents are also non-cariogenic 
and non-erosive
766
767 Table S2: Conclusions from Serra-Majem et al ( 2018)
Relevant to our 
consensus statement 
Blank = not 
addressed
1) LNCS are some of the most extensively evaluated dietary 
constituents, and their safety has been reviewed and confirmed by 
regulatory bodies globally including the World Health Organisation, the 
US Food and Drug Administration and the European Food Safety 
Authority;
2a1
2) Consumer education, which is based on the most robust scientific 
evidence and regulatory processes, on the use of products containing 
LNCS should be strengthened in a comprehensive and objective way;
2b1
2a5
3) The use of LNCS in weight reduction programmes that involve 
replacing caloric sweeteners with LNCS in the context of structured diet 
plans may favour sustainable weight reduction. 
Furthermore, their use in diabetes management programmes may 
contribute to a better glycaemic control in patients, albeit with modest 
results. 
1a1
1a3
1a4
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LNCS also provide dental health benefits when used in place of free 
sugars
4)It is proposed that foods and beverages with LNCS could be included 
in dietary guidelines as alternative options to products sweetened with 
free sugars;
2a3
3c1
3a4
5) Continued education of health professionals is required, since they are 
a key source of information on issues related to food and health for both 
the general population and patients. With this in mind, the publication of 
position statements and consensus documents in the academic literature 
are extremely desirable.
3a3
3c4
768
769
770
771 Table S3: Conclusions from Bright (2018) on Future Research Needs  
772 Blank = not addressed
Relevant to our 
consensus 
statement
Q1. Do LCSs aid weight loss and/or weight maintenance? 1a1 1b1 
Q2. Does LCS consumption modify appetite (hunger, fullness, desire to 
eat /prospective consumption) and/or total energy intake and, if so, how?
1a1, 1a2 
Q3. Does the use of LCSs affect insulin secretion, carbohydrate 
metabolism, or the gut microbiota and its function? If so, where is this 
happening (cognition, sweet receptors on tongue, receptors in 
gastrointestinal tract, etc.) and does it have any physiologic 
consequences on health?
1b1
Q4. Are there potential long-term health risks (obesity, diabetes, cancer, 
CVD, etc.) of LCS consumption in humans? Are certain population 
groups (diabetics, children, pregnant women, those with genetic disease) 
more susceptible to the potential health risk(s)?
1b1, 1b2
Q5. Is LCS sweetness perceived by the brain as energy in the same way 
as other sweeteners? Do those who are overweight or obese sense 
LCSs differently than normal-weight people?
Q6. Are there impacts of LCS consumption during pregnancy on the 
fetus?
Q7. Do LCSs differentially affect long-term food intake, eating frequency, 
and portion sizes in children, adolescents, and adults? Is there an impact 
on dietary quality and adherence to recommended dietary patterns?
1b4?
3b1
3b2
Q8. In individuals with diabetes and prediabetes, does chronic 
consumption of LCSs have an impact on glycemic control, alter glucose 
transport, or invoke a cephalic phase response?
1b5
Q9. Does LCS consumption affect consumption of other sweeteners or 
sugars or total carbohydrate intake? Is the effect different than that from 
consumption of nutritive sweeteners?
1b4
2b3
Q10. Do LCSs affect energy metabolism and fat storage? 1b1
Q11. Should study findings be evaluated for each LCS individually or 
collectively? To which health outcome(s) are the findings from individual 
1b3
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LCSs generalizable to the class of ingredients?
Q12. Is LCS intake accurately estimated in current dietary assessment 
tools?
2b3
Q13. Are there interactions between the combination of fat substitutes 
and sweetener substitutes on appetite (hunger, fullness, desire to eat or 
prospective consumption) and/or total energy intake?
related to 1b2
Q14. Is there any variation in how LCSs affect those of different ages, 
races, and ethnicities?
1b2
Q15. Do individuals with different dietary patterns (high protein vs. high 
carbohydrate, etc.) affect the metabolism of LCSs differently and, if so, 
how?
1b2
Q16. How do we design a system or methodology to address the 
differences in existing LCS compounds vs. compounds that will be 
emerging down the road?
2a1? 2b2
2b3
Q17. Do the effects of LCS consumption on body weight differ by sex? If 
so, what are the sex-specific mechanisms of the impact of LCS 
consumption on body weight?
1b2  
Q18. Has there been a gradual increase in the overall sweetness in our 
diet?
related to 1b4
773
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46 Abstract
47 A consensus workshop on low calorie sweeteners (LCS) was held in November 2018 where 
48 seventeen experts (the panel) discussed three themes identified as key to the science and 
49 policy of LCS: (1) weight management and glucose control; (2) consumption, safety and 
50 perception; (3) nutrition policy.  The aims were to identify the reliable facts on LCS, suggest 
51 research gaps and propose future actions. The panel agreed that the safety of LCS is 
52 demonstrated by a substantial body of evidence reviewed by regulatory experts and current 
53 levels of consumption, even for high users, are within agreed safety margins. even highest 
54 consumption estimates are not a concern. However, better risk communication is needed.. 
55 More emphasis is required on the role of LCS in helping people reduce their sugar and 
56 energy intake, which is a public health priority. TBased on reviews of clinical evidence to 
57 date, the panel concluded that LCS can be beneficial for weight management when they are 
58 used to replace sugar in products consumed in the diet (without calorie substitution). The 
59 available evidence suggests no grounds for concerns about adverse effects of LCS on sweet 
60 preference, appetite or glucose control. Concerns about adverse effects of LCS on sweet 
61 preference, appetite or glucose control are not supported by the evidence currently 
62 available; indeed, LCS may improve diabetic control and dietary compliance. Regarding 
63 effects on the human gut microbiota, Limited data are limited and dodoes not provide 
64 adequate evidence that LCS affects gut health at doses relevant to human use. Tthe effects 
65 of LCS on gut health at doses relevant to human use is currently based on limited evidence.  
66 The panel identified research priorities, including collation of the totality of evidence on LCS 
67 and body weight control, monitoring and modelling of LCS intakes, impacts on sugar 
68 reduction and diet quality and developing effective communication strategies to foster 
69 informed choice. There is also a need to reconcile policy discrepancies between 
70 organisations and reduce regulatory hurdles that impede low energy product development 
71 and reformulation.   
72
73 Introduction and aim of the Consensus Report
74
75 A number of reviews, some narrative and some systematic, have discussed the evidence for 
76 the safety of LCS and their effects on appetite, food intake, body weight, glucose control and 
77 other health outcomes (1) (2) (3; 4; 5; 6) (7) (8). Evidence has also been evaluated by authorities 
78 such as the European Food Safety Authority (EFSA), the (US) Dietary Guidelines Advisory 
79 Committee (DGAC), the French Agency for Food, Environmental and Occupational Health & 
80 Safety (ANSES) and Public Health England (PHE), who have issued statements or opinions 
81 on the use of low calorie sweeteners (9) (10; 11; 12; 13). Other groups of scientific experts 
82 have generated consensus statements, position papers, or other statements on LCS., These 
83 include including the British Dietetic Association, Diabetes UK, the American Heart 
84 Association and American Diabetes Association (AHA/ADA) (14) (15) (16) (17) (18; 19) (20).
85
86 This paper describes the results of a workshop in which seventeen experts convened to 
87 discuss and debate the science and policy relating to the use of low calorie sweeteners 
88 (LCS). The aims were to establish via consensus-forming techniques, clear and simple 
89 statements on LCS that all the panel agreed (facts), to highlight the areas where more 
90 research is required (gaps) and to propose how progress might be achieved (actions).  It is 
91 hoped that the provision of these statements on safety and potential benefits of LCS will 
92 assist health practitioners and policy makers to promote consistent messages and develop 
93 strategies based on sound science.  Identification of the gaps and actions will help promote 
94 better study designs, suggest priorities for research funding and thereby encourage more 
95 coherent public health policy.
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96 Background to LCS and their regulatory approval process
97
98 All LCS have undergone an extensive safety evaluation process by international and 
99 national regulatory food safety bodies both before and after their approval for use in the 
100 market.  The Food and Agriculture Organization (FAO)/World Health Organization (WHO) 
101 Joint Expert Committee on Food Additives (JECFA) (21), the US Food and Drug 
102 Administration (FDA) (22), and EFSA (9), have confirmed the safety of all approved LCS as 
103 food additives. . Hence there is an extensive body of evidence from both animal models and 
104 human studies that support the safety of LCS. Each compound is considered individually as 
105 their characteristics, metabolism and metabolic fates are different (23). Furthermore, there is 
106 an ongoing review process to ensure that any new information on safety is evaluated, for 
107 example recent scientific opinions by EFSA on aspartame and sucralose (24) (25).
108
109 As part of the LCS safety evaluations, the regulatory authorities establish the Acceptable 
110 Daily Intakes (ADI) for each sweetener (26). The ADI is defined as an estimate of the amount 
111 of a food additive, expressed per kg bodyweight, that can be ingested daily by individuals 
112 over a lifetime without appreciable risk to health. ‘Without appreciable risk’ means, based on 
113 the current knowledge, “certainty that no harm will result, even after a lifetime of exposure to 
114 the additive” (27). The current ADIs for LCS were established using the ‘No Observed 
115 Adverse Effect Level’ (NOAEL). The  ‘No Observed Adverse Effect Level’ (NOAEL)  This is 
116 the highest dietary level of an additive at which no adverse effects were observed in animal 
117 studies. The ADI is typically set at 1/100th of the NOAEL (10-fold reduction for inter-species 
118 variation and 10-fold reduction for intra-species variation) to give a large margin of safety for 
119 even the most sensitive consumer. The ADI refers to a lifelong exposure situation, not a 
120 single occasion, and thus infrequent consumption of levels higher than the ADI are not a 
121 health concern. Because of the large safety margin used in setting the ADI, it is likely that an 
122 ADI for a given additive would have to be exceeded by some considerable amount for an 
123 extended period of time for there to be any risk of harm to human health.  However, if an 
124 intake estimate indicates that the ADI may be regularly exceeded by certain sectors of the 
125 population, the regulatory authority may advise a reduction of levels in foods, or to reduce 
126 the range of foods in which the additive is permitted for use (27).  In some cases, the ADI 
127 may be “not specified” when the total potential intake from all possible sources does not 
128 represent a hazard to health, and hence no numerical ADI is needed. It should be noted that, 
129 in the future, the Benchmark Dose (BMD) will be the preferred approach for establishing a 
130 reference point (28).  However, discussion of the expert considerations and data 
131 requirements for calculation of a BMD is beyond the scope of this paper. 
132
133 In relation to efficacy, EFSA has a system for evaluating dossiers of evidence submitted for 
134 the substantiation of health claims (29).  In 2011, the EFSA Panel on Nutrition, Novel Foods 
135 and Food Allergens (NDA) concluded that there was sufficient scientific evidence to support 
136 the claims that intense sweeteners, like all sugar replacers, lead to a lower rise in blood 
137 sugar levels after meals if consumed instead of sugars, and maintain tooth mineralisation by 
138 decreasing tooth demineralisation; again if consumed instead of sugars. However at that 
139 time, EFSA’s experts found no clear cause and effect relationship to substantiate the claims 
140 that intense sweeteners when replacing sugars maintain normal blood sugar levels, or 
141 maintain/achieve a normal body weight (30).
142
143 There are currently various jurisdiction-specific restrictions on the use of LCS in foods and 
144 beverages. For example, under European legislation, sweeteners are only permitted if used 
145 to replace sugars for the production of energy-reduced food (i.e. with 30% less energy), non-
146 cariogenic food, or food with no added sugars (31). This limits the options available to 
147 manufacturers for more modest reformulation or stepwise reduction of sugar content in food 
148 and drink through the use of sweeteners.  
149  
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150 Methods 
151
152 The consensus workshop was designed to follow Workshop participants were speakers or 
153 chairs at a conference held by the International Sweeteners Association (ISA) in London on 
154 6th November 2018 entitled ‘The science behind low calorie sweeteners: where evidence 
155 meets policy’. The panel members were all speakers or chairs at that conference, chosen for 
156 their international expertise in LCS science and policy. The participants were chosen for their 
157 expertise in different aspects of LCS science and policy and for their international 
158 experience. The workshop was held the following day and chaired and facilitated by two 
159 independent consultants in nutrition science, (MA and SG), who drafted the paper and 
160 coordinated responses from participants. The ISA provided funds for the venue and 
161 speakers’ expenses. They  were observers at the workshop but had no control over the 
162 paper.ispaper.  Disclosures of interest for all authors are given.), who have drafted this paper 
163 and are joint authors with the panel of experts. 
164
165 The workshop leaders (MA and SG) identified 3 key Themes or topic areas for discussion at 
166 the workshop: 
167
168 1) Role of low calorie sweeteners in weight management and glucose control 
169 2) Consumption and safety of low calorie sweeteners and consumer perception 
170 3) Role of low calorie sweeteners in relation to nutrition policy 
171
172 As the workshop was time-limited the choice of themes was based on the pertinence in 
173 terms of current debates on LCS, and the available expertise represented by the panel.         
174
175 Prior to the workshop, each panel member was asked to provide feedback on 3 questions 
176 with respect to their own area of expertise:
177  
178 a. Statements of fact: what do we know? 
179 b. Questions and type of evidence needed (gaps: what do we still need to know?)
180 c. How this might translate to further research work or policy (actions: what should we 
181 do?). 
182
183
184 Comments were minimally edited by MA and SG to produce the Working Document (WD) 
185 with provisional statements/questions/actions for each Theme. 
186
187 At the workshop all the participants discussed the WD in detail. A scoring system (1=strongly 
188 disagree to 10=strongly agree) was used to evaluate level of agreement on the ‘facts’. 
189 Statements that achieved a high level of agreement were discussed further. Participants 
190 refined the wording of each statement to reach consensus. Having established agreement 
191 on the facts, participants identified the major gaps or research questions.  Finally, 
192 participants identified the most important ‘actions’ suggested in the WD and these were then 
193 summarised. Participants agreed to the process for further review and publication, i.e. that 
194 the workshop leaders would circulate the draft consensus document for comments, integrate 
195 responses and write the discussion before presenting the final article to all participants for 
196 review and approval. Table 1 shows the Timeline of the project.
197
198 Results
199
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200 The results are given below in the form of the consensus statements for the three Themes 
201 and the three questions relating to each Theme. The panel agreed the most pertinent 
202 references to cite for each consensus statement. 
203 Theme 1: Role of low calorie sweeteners in weight management and 
204 glucose control: the scientific evidence
205
206 1a Facts - What we know
207
208 1. When substituted for sugars to reduce energy density of foods and drinks, LCS 
209 reduce net energy intake and assist weight management (3; 5) (12) (13).
210
211 2. Intervention studies have shown that beverages containing LCS have at least a 
212 similar effect on appetite and energy intake to water (5; 32).
213
214 3. The collective evidence supports the conclusion that LCS have no adverse effect on 
215 blood glucose and insulin regulation (HbA1c, fasting and post-prandial glucose and 
216 insulin levels) in people with, and without, diabetes (2; 33) (34)
217
218 4. The potential value of LCS in dietary management of diabetes derives from their role 
219 as substitutes for sugars, and hence carbohydrates. (19).
220
221 5. Confounding by adiposity, and reverse causality can explain the positive association 
222 between LCS and T2DM and other cardiometabolic diseases, reported in some 
223 observational studies. (35) (36) (37).
224
225 6. Regarding effects involving the human gut microbiota, current evidence isdata are 
226 limited and do does not provide adequate evidence that LCS influence of effects of 
227 LCS gut health at doses relevant to human use(either negative or positive 
228 effects).(38)
229 1b Gaps:  What we don't know   
230
231 1. What are the long-term effects of LCS on glucose tolerance, gut function, 
232 cardiometabolic effects, gut microbiota and weight management?
233
234 2. How are these effects altered according to personal factors, such as age, sex, 
235 ethnicity, socio-economic status, health status, diet and lifestyle?
236
237
238 3. How do these effects differ according to dietary context (ad lib vs. weight-control diet) 
239 and form of LCS (in liquids or solids), and type or blend of LCS?
240
241 4. Does reducing exposure to sweetness have consequences for food choice and 
242 intake in the medium-to-long term? 
243
244
245 5. Can LCS help improve long term Type 2 diabetes (T2DM) management, when part of 
246 standard dietary and lifestyle approaches? 
247
248 1c Actions - What should be done?
249
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250 1. There is a need for a portfolio of well-designed RCTs (with appropriate time frame of 
251 a year or more) with different comparators and different carriers of LCS (food and 
252 beverage matrices). The trials should be conducted by level of ‘free sugar’ intake in 
253 different populations; they should use multiple endpoints (diet quality, gut microbiota 
254 function and metabolomics, and wider health and quality of life measures). They 
255 should be done in the context of weight-control diets, including for T2DM and also in 
256 non-restrictive diets.
257
258 2. There is a need for population cohort studies to model changes in weight/ 
259 cardiometabolic risk in the context of changes in LCS consumption, not baseline LCS 
260 values. The studies should include substitution analysis (e.g. LCS beverages for 
261 caloric beverages, water, etc.) and adjustment for adiposity. Their data should be 
262 made available for further analysis. 
263
264
265 3. There is a need for a collation of evidence to support future health claim submissions 
266 for LCS and body weight control, as data become available.
267
268 Theme 2 - Consumption and safety of low calorie sweeteners and consumer 
269 perception 
270 2a Facts - What we know
271
272 1. The safety of LCS is demonstrated by a substantial body of evidence as well as 
273 continued review by independent regulatory agencies/committees including: 
274 JECFA/Codex, FDA and EFSA (21) (22) (9). These organisations have taken into 
275 account of the decades of both positive and negative human and animal studies to 
276 draw their conclusions.  Continual monitoring and modelling of LCS exposures is 
277 undertaken and this demonstrates that intakes of LCS, even among high 
278 consumers, are within ADIs (39; 40) (41).
279
280 2. Currently, the major sources of LCS in the Western diet are beverages and table top 
281 sweeteners (39; 40; 42). 
282
283 3. LCS can be used to reduce the sugar and energy content of beverages and some 
284 foods whilst maintaining a similar sensory profile. The potential for energy reduction 
285 is more limited in foods and depends on the options for reformulation and hat 
286 replaces the bulk of sugar (43). LCS can be used synergistically in blends to achieve 
287 the desired sensory profile at lower levels of use.   
288
289 4. The collective evidence supports the conclusion that there is no relationship 
290 between adiposity and liking/ preference for sweet taste in either adults or 
291 children(44).
292
293 5. Consumer perceptions vary with regard to LCS, with some people having concerns 
294 about their potential health effects (14; 20).
295 2b Gaps – What we don't know
296
297 1. Which factors (including knowledge, attitudes and behaviours) influence consumer 
298 perception of risks and benefits of LCS consumption?  Are these the same for health 
299 professionals? 
300
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301 2. There is a need for in-depth data relating to current patterns on of LCS consumption 
302 at multiple levels, and across countries and regions, to strengthen the evidence base.  
303
304 3. There is a need for more reliable measures of LCS exposure, such as biomarkers. 
305 Further development of these and better linkage of food composition and dietary 
306 databases is needed to help monitor changing use and consumption of LCS. 
307 2c Actions - What should be done?
308
309 1. There is a need to research and develop evidence-based strategies to communicate 
310 all of the above to consumers, health professionals and policy makers. The extensive 
311 body of scientific evidence that backs regulatory approval and the on-going safety 
312 assessment of LCS can then encourage better informed public health decisions. The 
313 media orf other organisations could be signpostedprovided, for example, with simple 
314 explanations of the ADI. 
315
316 2. There is a need to develop communications to foster more informed public attitudes 
317 towards LCS, for example by emphasizing the potential health gains associated with 
318 sugar (and energy) intake reduction and the role of LCS in achieving this. It is 
319 important to explain that the overall impact of LCS will depend on the amount of 
320 sugars replaced in the diet and the overall reduction in calorie (energy) intake that 
321 ensues. Use of LCS alone cannot be expected to act as a ‘silver bullet’ for weight 
322 loss.
323
324
325 3. Research into biomarkers for individual LCS is needed to complement the exposure 
326 assessment based on consumption records. There is a need to improve linkage of 
327 databases and to model intakes in future scenarios.   
328
329 Theme 3 - Role of low calorie sweeteners in relation to nutrition policy 
330
331 3a Facts - What we know
332
333 1. Reduction in the intake of ‘free sugars’ and ‘added sugars’ is being recommended 
334 around the world to reduce the risk and prevalence of obesity, which is a major public 
335 health concern (10) (45) (46). LCS is one of the strategies to consider.
336
337 2. LCS can be useful in dietary approaches to both prevent and manage diabetes and 
338 obesity. Benefit will depend on how foods and beverages containing LCS are 
339 substituted, as well as on the overall quality of the diet and the overall energy 
340 provision (16).
341
342 3. Despite repeated and consistent reassurances from food safety authorities, there is 
343 still some distrust of LCS among health professionals and policy makers. (47)
344
345 4. Some policies acknowledge LCS consumption as a useful strategy to reduce sugars 
346 intake (12).  However, there are discrepancies with other national and international 
347 policies (10; 11) and regarding use in children. 
348 3b Gaps - What we don't know
349
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350 1. Can LCS help individuals meet the population level dietary recommendations for 
351 reduction of sugars intake  (e.g. to 5% (average) (48) or 10% (for individuals) (10; 45)?  
352 If so, how can this be achieved? 
353
354 2. How does a dietary approach that includes LCS-sweetened foods and drinks affect 
355 dietary quality compared to low-sugar diets?
356
357
358 3. What are the best strategies to communicate LCS safety and efficacy to interested 
359 parties such as health professionals and the general public?
360  
361 3c Actions - What should be done?
362
363 1. There is a need to model the potential for LCS to reduce sugar content and sugar 
364 intakes whilst ensuring that other dietary recommendations can also be met in the 
365 overall diet. 
366
367 2. Trends in dietary intake of LCS need to be monitored, linked with food and beverage 
368 reformulation and ultimately with health outcomes.  
369
370 3.  Policies relating to LCS from different countries should be reviewed to compare their 
371 remit, priorities, evidence base and interpretation.
372
373 4. To help reconcile policy discrepancies, policy -makers, scientists and regulatory 
374 affairs experts should agree on their understanding of the role of LCS in the diet.
375
376 5. In the context of sugar reduction and obesity, it would be helpful to review the 
377 regulatory and public health policy hurdles that prevent wider use of LCS in food 
378 products for those sweeteners where dietary intake is very low compared to the ADI.
379
380 DISCUSSION
381 Strengths and limitations of approach
382
383 The methodology followed a planned and transparent process. All 17 experts were 
384 requested ahead of the workshop to generate a summary of their topic in the form of 
385 answers to the three questions. These were then collated under three Themes by the 
386 workshop leaders and combined for the working document, which was circulated prior to the 
387 workshop. At the start of the group discussion, scoring was used as a consensus-forming 
388 technique to allow participants to indicate the strength of their agreement with each 
389 statement. Alternative forms of wording suggested by participants were considered in order 
390 to improve clarity of each statement. The resulting statements were circulated after the 
391 workshop, with supporting references, to allow for further reflection and improvement. A 
392 strength of the process was the expertise represented on the panel in many aspects of LCS 
393 (including toxicology, regulation, food science, medicine, microbiology, psychology, 
394 epidemiology, public health nutrition and dietetics).  Finally, holding the workshop 
395 immediately after a scientific conference on the topic ensured that all experts were fully 
396 prepared and engaged to discuss the issues and formulate consensus. 
397
398 The workshop was wide in ,scope but was not intended to be exhaustive; the themes were 
399 selected as being pertinent to current debate on LCS and within scope of the expertise of the 
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400 panel. Consensus was based on expert opinion and key references including systematic 
401 reviews; the group did not review all the primary literature on these themes. Other possible 
402 limitations of the methodology were that all our participants were scientists or public health 
403 experts, unlike the broader stakeholder panel used by Bright et al. (49).  The workshop was 
404 instigated and funded by ISA; however, ISA had no control over the choice of Themes, and 
405 no role in the discussion or this paper. Participants all acted completely independently to 
406 express their views in open debate and to contribute to the resulting paper. 
407
408 Comparison with other consensus papers relating to LCS 
409 Goals and methodology
410 To our knowledge, there have been three previous papers published in English that contain 
411 consensus statements about LCS (14) (15) (49). In addition, there have been a number of 
412 position papers and evidence reviews whose methodology and scope differ from that of the 
413 present report and these are discussed later. 
414 The goal of the consensus report by Gibson et al. (14) was to summarise the role and 
415 potential benefits of LCS on appetite, energy intake, body weight, diabetes and dental health 
416 to give clarity to health professionals and educators on use of LCS. The goal of the Ibero–
417 American Consensus on LCS (15) was “to develop a consensus on the use of low- and no-
418 calorie sweeteners as substitutes for sugars and other caloric sweeteners in line with current 
419 international public health recommendations, in the context of the prevention and treatment 
420 of obesity and related diseases in Latin American countries”. The report (15) also provides a 
421 comprehensive overview of the position of international and national regulatory bodies on 
422 LCS safety and efficacy studies on individual LCS. Both these consensus reports (14) 15) 
423 were compiled by panels limited to international scientists and public health experts.  
424 The report by Bright et al. (49), focused on future research needs, and involved a wider 
425 stakeholder panel who participated in interactive webinars, surveys and interviews with the 
426 research team and generated a list of 18 questions across 5 broad research areas, ranking 
427 them in order of priority. The stakeholder panel was recruited according to the “7 P’s” of 
428 stakeholder engagement  i.e. patients, providers, researchers, policymakers, product 
429 makers, payers, and purchasers (50). It therefore included policymakers, lay audience 
430 members, health providers, a research funder, individuals with food industry experience, and 
431 researchers of several different specialties. 
432 Content and conclusions
433 The consensus statements agreed by our expert panel were produced independently but 
434 have been compared with previous consensus statements in Table 2. Further details can be 
435 found in supplementary Tables S1 and S2. Some topics were not covered in other reports: 
436 for example, the statements in this paper have included association between sweetness 
437 preference and obesity, effects of LCS on gut bacteria and sources of LCS, which were not 
438 covered by Gibson et al. (14)or Serra-Majem et al. (15); conversely, this panel did not 
439 consider the effects of LCS on dental health. 
440 Table 2 shows there was broad agreement between the sentiments expressed in our 
441 statements and these two reports.
442
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443 The gaps identified by our panel have been compared with the research priorities from Bright 
444 et al. (49) (Table S3).  Most of the important future research questions identified by their 
445 stakeholder panel were also selected by our panel as areas in need of study. In the case of 
446 effects of LCS beverages on appetite and energy intake (Bright et al. (49) Q2), our panel 
447 considered the evidence to be sufficiently strong for ‘no effect or at least similar effect’ 
448 compared to water to be classed as fact, and for a reduction in energy intake compared to 
449 sugar also to be classed as fact.  Research gaps identified by our panel and not identified by 
450 Bright et al. (49) included research on biomarkers of LCS consumption to aid intake 
451 assessments, research on communication with consumers and other stakeholders about 
452 LCS and more research on issues related to policy. Conversely Bright’s (49) questions on the 
453 sensing of LCS by the brain and the impact of LCS on the fetus, did not feature directly in 
454 our workshop discussion.
455 Comparison with other reviews and position statements  
456  
457  In 2011 EFSA was also of the opinion that a cause and effect relationship had not been 
458 established between the use of intense sweeteners and maintenance of normal body weight 
459 or blood glucose, but several high quality studies and reviews have since been published 
460 (51) (52) (53; 54) and others are currently underway: the SWITCH project (55) and the SWEET 
461 project;(available at  https://sweetproject.eu) .  A number of reviews and position statements 
462 have addressed the evidence for and against health benefits of LCS. Our panel observed 
463 that differences between the positions and policies of different organisations with regard to 
464 LCS are a cause of confusion. Reasons for discrepancies may include different remits and 
465 approaches and different interpretations of the evidence base. With regard to the science, 
466 the data are insufficient to answer some questions conclusively, given the multiple 
467 components involved .  The goal of systematic review and meta-analysis is frequently 
468 hampered by differing study designs that make comparison difficult and meta-analysis 
469 unreliable; hence the need for cautious wording, which may be interpreted as a negative 
470 statement. Reviews differ in scope and the precise research question asked, resulting in 
471 differences in study selection that lead to different conclusions. It is important to clearly 
472 establish that LCS are food additives and, as such cannot provide health benefits, except in 
473 relation to the reduction of sugar within an adequate diet and lifestyle. Our panel concluded 
474 that, when used to replace dietary sugar, the use of LCS use facilitates reduction in energy 
475 intake and weight loss. This was based on evidence from RCTs of 6m to 2 years in length 
476 and recent systematic reviews that pay careful attention to appropriate comparators. The 
477 panel also stated the need for studies of longer-term effects. By contrast, a recent wide-
478 ranging review on health effects of non-sugar sweeteners (which in practice was were LCS 
479 as it polyols were excluded. polyols) concluded that “there were no significant or clinically 
480 important effects on most outcomes” (8). However due to very strict inclusion and exclusion 
481 criteria, their analyses omitted some notable studies on body weight  (51; 52),(53) (54) and 
482 combined studies with different comparators, potentially diluting the effect size (56).  Another 
483 recent review (57) has been criticised on the same grounds (37). Toews et al. (8) also stated 
484 that “potential harms from the consumption of non-sugar sweeteners could not be excluded”, 
485 a statement which relates to lack of evidence, not evidence of harm. Our panel took a harm-
486 reduction approach, where LCS are a desirable substitute for sugar and one route to helping 
487 achieve sugar and energy reduction whilst still maintaining dietary diversity and pleasure.   
488
489 Other position statements, particularly those published before 2014, have offered cautious 
490 conclusions on potential benefits of LCS. For example, the 2012 joint scientific statement 
491 from the American Heart Association and the American Diabetes Association (AHA/ADA) 
492 (37) concluded that “at present there are insufficient data to determine conclusively that non-
493 nutritive sweeteners (NNS) benefit appetite, energy intake or body weight” (20). However, the 
494 AHA/ADAis document also stated that “when used judiciously, NNS could facilitate 
495 reductions in added sugars intake, thereby resulting in decreased total energy and weight 
496 loss/weight control and promoting beneficial effects on related metabolic parameters”. 
Commented [sg1]:  moved from further down this 
section 
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497
498 In 2011 EFSA was also of the opinion that a cause and effect relationship had not been 
499 established between the use of intense sweeteners and maintenance of normal body weight 
500 or blood glucose, but several high quality studies and reviews have since been published 
501 (51) (52) (53; 54) and others are currently underway: the SWITCH project (55) and the SWEET 
502 project; https://sweetproject.eu.  The latest AHA advisory statement (19) (which focussed on 
503 LCS beverages and cardiometabolic outcomes) concluded that the use of LCS beverages 
504 may be an effective strategy to help control energy intake and promote weight loss. 
505 Nonetheless, due to the lack of long-term trials in children, the AHA , but thought it prudent 
506 to advise against prolonged consumption of LCS beverages by children, preferring water, 
507 other  unsweetened beverages or milk as the primary drink. Policy statements from 
508 professional bodies of dietitians and nutritionists have generally been pragmatic, seeing LCS 
509 as a helpful tool in helping people reduce their sugar intake and manage their weight, whilst 
510 stressing the importance of the context, namelyin the context of  a healthy balanced diet that 
511 meets other dietary recommendations (16) (17; 18). 
512 Extension of our consensus statements to actions and policies 
513 The main strategy of our consensus workshop was to stimulate forward thinking as well as to 
514 restate principles. The consensus statements on actions put the focus firmly on what is 
515 required to deliver. For example, the panel made recommendations for further long-term 
516 randomised controlled trials of LCS with different comparators and multiple endpoints, for 
517 prospective studies that control for adiposity and other confounders, and for better estimates 
518 of LCS exposure. Such recommendations may help research funding bodies select priorities. 
519 Clarity and consistency of policy would be improved by a comprehensive evaluation of all the 
520 evidence on effects of LCS.  Others have also called for larger and longer clinical trials with 
521 careful selection of comparators (7) (37) (44) (58). The review by Toews et al. (8) was also 
522 critical of the size, short duration, and methodological and reporting quality of studies. It also 
523 called for more data on benefits and risks of non-sugar sweeteners in doses and patterns 
524 more akin to real life consumption (8). Our expert panel considered the safety data to be 
525 incontrovertible robust but agreed that there is a continued need for ongoing exposure 
526 assessment to account for changing LCS use, and also consideration of any new evidence 
527 that might emerge. Novel recommendations made by the panel included better strategies 
528 and methods to improve communications about the safety and efficacy of LCS, modelling of 
529 the effect of LCS on sugar reduction and diet quality, relaxing regulation to increase the 
530 potential for reformulation using LCS, and review and reconciliation of policy differences on 
531 the use of LCS.  
532
533 Conclusion
534
535 The panel considered that the substantial body of evidence concerning LCS safety should 
536 be communicated in a consistent manner. More emphasis is required on the role of LCS in 
537 helping people reduce their sugar and energy intake, which is a public health priority. 
538
539 Research priorities should include 
540 a. a dossier of the totality of evidence on LCS and body weight control, 
541 b. studies to monitor and model LCS intakes and their impact on sugar reduction and 
542 diet quality,
543 c. effective communication strategies to inform consumers, non- governmental 
544 organisations (NGOs), health professionals, research funding bodies and the food 
545 and beverage industry 
546
547 Efforts should be made to understand and, where possible, reconcile policy discrepancies 
548 between organisations and reduce regulatory hurdles that impede product development and 
549 reformulation designed to reduce sugars and/or calories. 
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550
551 It is hoped that these consensus statements and recommendations arising from the expert 
552 workshop will assist policy makers, and other stakeholders including NGOs, health 
553 professionals, research funding bodies and the food and beverage industry.
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764 Table 1: Timeline of the project
765
January 2018 Identification of ISA conference speakers and chairs 
April 2018 Workshop leaders (MA & SG) appointed
Conference speakers and chairs invited to workshop
May 2018 Three key workshop Themes identified by workshop 
leaders
May 2018 Workshop leaders agree questions for experts and based 
on the 3 Themes for workshop
July 2018 Experts asked to provide provisional answers to questions
September 2018 Workshop leaders collate expert comments into 
WDworking document
November 6th, 2018 ISA Conference
November 7th, 2018 Expert workshop
November 2018 Draft consensus statements agreed at workshop, 
circulated to experts
December 2018 Comments received from experts
December 2018- January 
2019
Draft paper written by workshop leaders
January 2019 Draft paper circulated to experts for approval
February 2019 Paper finalised and submitted to journal
July and August 2019 Revisions to paper agreed by panel
766
767
768
769
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770
771 Table 2: Comparison of our consensus statements on LCS with those of 
772 others.
773 (+ = broad correspondence with our Consensus statements; blank = not (or not 
774 fully) addressed) 
775
Theme 1:
Role of low calorie sweeteners in weight management and glucose 
control: the scientific evidence
Gibson 
et al 
(2014) 
(14)
Serra- 
Majem 
et al ( 
2018) 
(15)
1. When substituted for sugars to reduce energy density of foods 
and drinks, LCS can reduce net energy intake and assist weight 
management.
+ +
2. Intervention studies have shown that LCS beverages have at 
least a similar effect on appetite and energy intake to water +
3. The collective evidence supports the conclusion that LCS have no 
adverse effect on blood glucose and insulin regulation (HbA1c, 
fasting and post-prandial glucose and insulin levels) in people 
with, and without, diabetes 
+ +
4. The potential value of LCS in dietary management of diabetes 
derives from their role as substitutes for sugars. and hence 
carbohydrates. 
+ +
5. Confounding by adiposity, and reverse causality can explain the 
positive association between LCS and T2DM and other 
cardiometabolic diseases, reported in some observational 
studies. 
+
6. Regarding effects involving the human gut microbiota, current 
evidence is limited and does not provide adequate evidence that 
LCS influence of effects of LCS gut health at doses relevant to 
human use(either negative or positive effects). 
Theme 2:
Consumption and safety of low calorie sweeteners and 
consumer perception
1. The safety of LCS is demonstrated by a substantial body of 
evidence as well as continued review by independent regulatory 
agencies/committees including: JECFA/Codex, FDA and EFSA 
These organisations have taken into account of the decades of 
both positive and negative human and animal studies to draw 
their conclusions.  Continual monitoring and modelling of LCS 
exposures is undertaken and this demonstrates that intakes of 
LCS, even among high consumers, are within ADIs
+
2. Currently, the major sources of LCS in the Western diet are 
beverages and table top sweeteners 
3. LCS can be used to reduce the sugar and energy content of 
beverages (and some foods) whilst maintaining a similar sensory 
profile. The potential for energy reduction is more limited in foods 
and depends on the options for reformulation and what replaces 
the bulk of sugar. LCS can be used synergistically in blends to 
achieve the desired sensory profile at lower levels of use
+ +
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4. The collective evidence supports the conclusion that there is no 
relationship between adiposity and liking/ preference for sweet 
taste in either adults or children
5. Consumer perceptions vary with regard to LCS, with some people 
having concerns about their potential health effects + +
Theme 3:
Role of low calorie sweeteners in relation to nutrition policy
1. Reduction in the intake of ‘free sugars’ and ‘added sugars’ is 
being recommended around the world to reduce the risk of 
obesity, which is a major public health concern. LCS should be 
one of the strategies to consider.
+ +
2. LCS can be useful in dietary approaches to both prevent and 
manage diabetes and obesity. Benefit will depend on how foods 
and beverages containing LCS are substituted, as well as on the 
overall quality of the diet and the overall energy provision.
+ + 
3. Despite repeated and consistent reassurances from food safety 
authorities, there is still some distrust of LCS among health 
professionals and policy makers 
+ +
4. Some polices acknowledge LCS consumption as a useful 
strategy to reduce sugars intake However, there are 
discrepancies with other national and international policies and 
regarding use in children. 
+ 
776
777
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779 Supplementary information 
780
781 Comparison of Consensus statements from others with the Consensus 
782 statements in this paper
783
784 Table S1: Conclusions from Gibson et al. (2014)
785
Relevant to our 
consensus 
statement
Blank = not 
addressed
(1) LCS do not increase appetite and have no discernible effect on 
satiety
1a2
(2).LCS help to reduce energy when used in place of higher energy 
ingredients
1a1
(3).LCS can enhance weight loss under real-life conditions when used as 
part of a behavioural weight loss programme
1a1
(4).LCS may have a beneficial effect on post-prandial glucose and insulin 
in healthy individuals and in people with diabetes
1a3
1a4
(5).LCS have dental benefits when used in food, beverages, toothpaste 
and medications, provided other constituents are also non-cariogenic 
and non-erosive
786
787 Table S2: Conclusions from Serra-Majem et al ( 2018)
Relevant to our 
consensus statement 
Blank = not 
addressed
1) LNCS are some of the most extensively evaluated dietary 
constituents, and their safety has been reviewed and confirmed by 
regulatory bodies globally including the World Health Organisation, the 
US Food and Drug Administration and the European Food Safety 
Authority;
2a1
2) Consumer education, which is based on the most robust scientific 
evidence and regulatory processes, on the use of products containing 
LNCS should be strengthened in a comprehensive and objective way;
2b1
2a5
3) The use of LNCS in weight reduction programmes that involve 
replacing caloric sweeteners with LNCS in the context of structured diet 
plans may favour sustainable weight reduction. 
Furthermore, their use in diabetes management programmes may 
contribute to a better glycaemic control in patients, albeit with modest 
results. 
1a1
1a3
1a4
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LNCS also provide dental health benefits when used in place of free 
sugars
4)It is proposed that foods and beverages with LNCS could be included 
in dietary guidelines as alternative options to products sweetened with 
free sugars;
2a3
3c1
3a4
5) Continued education of health professionals is required, since they are 
a key source of information on issues related to food and health for both 
the general population and patients. With this in mind, the publication of 
position statements and consensus documents in the academic literature 
are extremely desirable.
3a3
3c4
788
789
790
791 Table S3: Conclusions from Bright (2018) on Future Research Needs  
792 Blank = not addressed
Relevant to our 
consensus 
statement
Q1. Do LCSs aid weight loss and/or weight maintenance? 1a1 1b1 
Q2. Does LCS consumption modify appetite (hunger, fullness, desire to 
eat /prospective consumption) and/or total energy intake and, if so, how?
1a1, 1a2 
Q3. Does the use of LCSs affect insulin secretion, carbohydrate 
metabolism, or the gut microbiota and its function? If so, where is this 
happening (cognition, sweet receptors on tongue, receptors in 
gastrointestinal tract, etc.) and does it have any physiologic 
consequences on health?
1b1
Q4. Are there potential long-term health risks (obesity, diabetes, cancer, 
CVD, etc.) of LCS consumption in humans? Are certain population 
groups (diabetics, children, pregnant women, those with genetic disease) 
more susceptible to the potential health risk(s)?
1b1, 1b2
Q5. Is LCS sweetness perceived by the brain as energy in the same way 
as other sweeteners? Do those who are overweight or obese sense 
LCSs differently than normal-weight people?
Q6. Are there impacts of LCS consumption during pregnancy on the 
fetus?
Q7. Do LCSs differentially affect long-term food intake, eating frequency, 
and portion sizes in children, adolescents, and adults? Is there an impact 
on dietary quality and adherence to recommended dietary patterns?
1b4?
3b1
3b2
Q8. In individuals with diabetes and prediabetes, does chronic 
consumption of LCSs have an impact on glycemic control, alter glucose 
transport, or invoke a cephalic phase response?
1b5
Q9. Does LCS consumption affect consumption of other sweeteners or 
sugars or total carbohydrate intake? Is the effect different than that from 
consumption of nutritive sweeteners?
1b4
2b3
Q10. Do LCSs affect energy metabolism and fat storage? 1b1
Q11. Should study findings be evaluated for each LCS individually or 
collectively? To which health outcome(s) are the findings from individual 
1b3
Page 43 of 43
Cambridge University Press
Nutrition Research Reviews
For Peer Review
22
LCSs generalizable to the class of ingredients?
Q12. Is LCS intake accurately estimated in current dietary assessment 
tools?
2b3
Q13. Are there interactions between the combination of fat substitutes 
and sweetener substitutes on appetite (hunger, fullness, desire to eat or 
prospective consumption) and/or total energy intake?
related to 1b2
Q14. Is there any variation in how LCSs affect those of different ages, 
races, and ethnicities?
1b2
Q15. Do individuals with different dietary patterns (high protein vs. high 
carbohydrate, etc.) affect the metabolism of LCSs differently and, if so, 
how?
1b2
Q16. How do we design a system or methodology to address the 
differences in existing LCS compounds vs. compounds that will be 
emerging down the road?
2a1? 2b2
2b3
Q17. Do the effects of LCS consumption on body weight differ by sex? If 
so, what are the sex-specific mechanisms of the impact of LCS 
consumption on body weight?
1b2  
Q18. Has there been a gradual increase in the overall sweetness in our 
diet?
related to 1b4
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